Twenty years on from the first pregnancies after preimplantation genetic diagnosis, Alan Handyside argues that informed prospective parents are largely good guides to the use of the thriving technology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Alan Handyside has a patent application for a method of analysing SNP data from single cells, and the clinic at the London Bridge Fertility, Gynaecology and Genetics Centre where he works has a private lab (Bridge Genoma) for PGD testing. He is also an unpaid consultant with Reprogenetics, a PGD-testing lab in West Orange, New Jersey, USA.
Rights and permissions
About this article
Cite this article
Handyside, A. Let parents decide. Nature 464, 978–979 (2010). https://doi.org/10.1038/464978a
Published:
Issue Date:
DOI: https://doi.org/10.1038/464978a
This article is cited by
-
Competing Views of Embryos for the Twenty-First Century: Textbooks and Society
Science & Education (2013)
-
Successful hematopoietic SCT from non-identical twins to two sisters with β-thalassemia major by using preimplantation genetic diagnosis and HLA typing
Bone Marrow Transplantation (2011)
